FibroGen Inc (NAS:FGEN)
$ 1.3 0.02 (1.56%) Market Cap: 129.32 Mil Enterprise Value: 101.67 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 57/100

FibroGen Inc at SVB Leerink Global Healthcare Conference (Virtual) Transcript

Feb 25, 2021 / 08:40PM GMT
Release Date Price: $49.86 (-5.94%)
Geoffrey Craig Porges
SVB Leerink LLC, Research Division - Director of Therapeutics Research & Diversified Biopharma and Senior Research Analyst

Good afternoon, everybody, and welcome to our next company presentation here at the Global Healthcare Conference. I'm joined by Enrique Conterno, who's the Chief Executive Officer of FibroGen; and Mike Tung from the Investor Relations group of FibroGen. Enrique and Mike, thank you for joining us today.

Enrique A. Conterno
FibroGen, Inc. - CEO & Director

Now thank you very much for the invitation, Geoff. Pleasure to be here. Thanks, Geoff.

Geoffrey Craig Porges;Enrique A. Conterno<
SVB Leerink LLC, Research Division - Director of Therapeutics Research & Diversified Biopharma and Senior Research Analyst

I look forward to chatting as it's a very exciting time for FibroGen. Enrique, so maybe you could give us a sense of what you're all focused on, what the activities that are engaging your leadership team and the rest of the company right now.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot